Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Medications improve quality of life for men with lower urinary tract symptoms.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.

Using a laser to remove hair in the urethra after hypospadias repair is effective and minimally invasive.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Uterine transplants for transgender women are feasible but need more research.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

The best method for urethral reconstruction is using hypoxia-preconditioned stem cells with autologous cells on a vascularized synthetic scaffold.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

The root extract of Untica mairei Levl may help treat benign prostatic hyperplasia.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Patients follow treatment well, but many change medicines; good information helps compliance.

Buccal mucosa grafts work well for urethroplasty in rabbits.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Tamsulosin works faster, but both drugs have similar effects after 6 months.